AUSTRALIA’S medicines regulator, the Therapeutic Goods Administration (TGA), is set to hand down its “interim decision” on whether it will make cannabidiol (CBD) more easily and affordably available for Australians. CBD is a non-psychoactive component of medicinal cannabis that can […]